Oruka Therapeutics, Inc. Investment Income, Interest and Dividend
Oruka Therapeutics, Inc. (ORKA) reported Investment Income, Interest and Dividend of $2.02 million for the 114-month period ending 2011-06-30, per its 10-Q filed 2011-08-15.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterestAndDividend · last filed 2011-08-15
- Oruka Therapeutics, Inc. investment income, interest and dividend for the quarter ending 2010-06-30 was $1.00K.
| Period end | Investment Income, Interest and Dividend 3 month | Investment Income, Interest and Dividend 6 month | Investment Income, Interest and Dividend 114 month |
|---|---|---|---|
| 2011-06-30 | $1.00K 10-Q · filed 2011-08-15 | $2.02M 10-Q · filed 2011-08-15 | |
| 2010-06-30 | $1.00K 10-Q · filed 2011-08-15 | $2.00K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |